ROBERT HERSHBERG - 04 Mar 2025 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Robert Hershberg by Kyle Piskel, Attorney-in-Fact
Issuer symbol
ADPT
Transactions as of
04 Mar 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2025, 19:15:16 UTC
Previous filing
12 Feb 2025
Next filing
12 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +15,394 +14% $0.000000 122,690 04 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (right to buy) Award $0 +23,726 $0.000000 23,726 04 Mar 2025 Common Stock 23,726 $8.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates.